Gender-related differences in circadian rhythm of rat plasma acetyl- and butyrylcholinesterase: Effects of sex hormone withdrawal

Chemico-Biological Interactions

Volumn 186, Issue 1, 2010, Pages 9-15

  Alves Amaral, Gracielle ^a   Pires Oliveira, Marcelo ^a   Andrade Lopes, Ana Luiza ^a   Chiavegatti, Tiago ^a   Godinho, Rosely Oliveira ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acetylcholinesterase; AChE, acetylcholinesterase; AP 1, activator protein 1; ASCh, acetylthiocholine; Blood; BuChE, butyrylcholinesterase; BuSCh, butyrylthiocholine; Butyrylcholinesterase; Circadian cycle; DTNB, 5,5 dithio bis(2 nitrobenzoic acid); EDTA, ethylenediaminetetraacetic acid; ERE, estrogen responsive element; Iso OMPA, tetraisopropyl pyrophosphoramide; Oct 1, octamer motif binding factor 1; PEA 3, polyoma enhancer activator 3; Sex hormones

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; SEX HORMONE;

ARTICLE; CASTRATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HORMONE DEFICIENCY; LIVER LEVEL; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; SEX HORMONE DETERMINATION; TISSUE DISTRIBUTION;

ACETYLCHOLINESTERASE; ANIMALS; BODY WEIGHT; BUTYRYLCHOLINESTERASE; CASTRATION; CIRCADIAN RHYTHM; FEMALE; GONADAL STEROID HORMONES; LIVER; MALE; ORGAN SIZE; RATS; RATS, WISTAR; SEX CHARACTERISTICS;

RATTUS;

EID: 77953124945     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.04.002     Document Type: Article

References (63)

1. Chatonnet A., Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J. 1989, 260:625-634.
2. Jbilo O., Toutant J.P., Vatsis K.P., Chatonnet A., Lockridge O. Promoter and transcription start site of human and rabbit butyrylcholinesterase genes. J. Biol. Chem. 1994, 269:20829-20837.
3. Kalow W., Gunn D.R. The relation between dose of succinylcholine and duration of apnea in man. J. Pharmacol. Exp. Ther. 1957, 120:203-214.
4. Scholler K.L., Goedde H.W., Benkmann H.G. Use of serum-cholinesterase in succinylcholine apnea. Can. Anaesth. Soc. J. 1977, 24:396-400.
5. Schwarz M., Glick D., Loewenstein Y., Soreq H. Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons. Pharmacol. Ther. 1995, 67:283-322.
6. Lynch T.J., Mattes C.E., Singh A., Bradley R.M., Brady R.O., Dretchen K.L. Cocaine detoxification by human plasma butyrylcholinesterase. Toxicol. Appl. Pharmacol. 1997, 145:363-371.
7. Li B., Stribley J.A., Ticu A., Xie W.H., Schopfer L.M., Hammond P., Brimijoin S., Hinrichs S.H., Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 2000, 75:1320-1331.
8. Massoulie J., Pezzementi L., Bon S., Krejci E., Vallette F.M. Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 1993, 41:31-91.
9. Layer P.G. Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 1996, 28:491-495.
10. Soreq H., Seidman S. Acetylcholinesterase-new roles for an old actor. Nat. Rev. Neurosci. 2001, 2:294-302.
11. Karczmar A.G. Metabolism of acetylcholine: synthesis and turnover. Exploring the Vertebrate Central Cholinergic Nervous System 2007, 81-148. Springer, New York. A.G. Karczmar (Ed.).
12. Fujimoto D. Serotonin-sensitive aryl acylamidase activity of acetylcholinesterase. FEBS Lett. 1976, 71:121-123.
13. George S.T., Balasubramanian A.S. The aryl acylamidases and their relationship to cholinesterases in human-serum, erythrocyte and liver. Eur. J. Biochem. 1981, 121:177-186.
14. Boopathy R., Rajesh R.V., Darvesh S., Layer P.G. Human serum cholinesterase from liver pathological samples exhibit highly elevated aryl acylamidase activity. Clin. Chim. Acta 2007, 380:151-156.
15. Montenegro M.F., Moral-Naranjo M.T., de la Cadena M.P., Campoy F.J., Munoz-Delgado E., Vidal C.J. The level of aryl acylamidase activity displayed by human butyrylcholinesterase depends on its molecular distribution. Chem. Biol. Interact. 2008, 175:336-339.
16. Grace M.S., Besharse J.C. Solubilization and biochemical-characterization of the melatonin deacetylase from xenopus-laevis retina. J. Neurochem. 1993, 60:990-999.
17. Greig N.H., Utsuki T., Yu Q.S., Zhu X.X., Holloway H.W., Perry T., Lee B., Ingram D.K., Lahiri D.K. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase. Curr. Med. Res. Opin. 2001, 17:159-165.
18. Abbott C.A., Mackness M.I., Kumar S., Olukoga A.O., Gordon C., Arrol S., Bhatnagar D., Boulton A.J.M., Durrington P.N. Relationship between serum butyrylcholinesterase activity, hypertriglyceridemia and insulin sensitivity in diabetes-mellitus. Clin. Sci. 1993, 85:77-81.
19. Alcantara V.M., Chautard-Freire-Maia E.A., Scartezini M., Cerci M.S.J., Braun-Prado K., Picheth G. Butyrylcholinesterase activity and risk factors for coronary artery disease. Scand. J. Clin. Lab. Investig. 2002, 62:399-404.
20. Das U.N. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med. Sci. Monit. 2007, 13:RA214-RA221.
21. Maric C. Sex, diabetes and the kidney. Am. J. Physiol. Renal Physiol. 2009, 296:F680-F688.
22. Dias M.A., Souccar C., Goulart M.D., Lapa A.J., do Valle J.R. Cholinesterase activity in developing rat skeletal muscles. Exp. Neurol. 1982, 76:538-546.
23. Godinho R.O., Lima-Landman M.T., Souccar C., Lapa A.J. Trophic control of cholinesterase activity in a testosterone-dependent muscle of the rat: effects of castration and denervation. Exp. Neurol. 1987, 96:558-568.
24. Godinho R.O., Souccar C., Lapa A.J. Testosterone control of endplate and non-endplate acetylcholinesterase in the rat levator ani muscle. Neurochem. Res. 1994, 19:657-663.
25. Pereira R.T.D., Porto C.S., Godinho R.O., Abdalla F.M.F. Effects of estrogen on intracellular signaling pathways linked to activation of muscarinic acetylcholine receptors and on acetylcholinesterase activity in rat hippocampus. Biochem. Pharmacol. 2008, 75:1827-1834.
26. Alves-Amaral G., Chiavegatti T., Pires-Oliveira M., Andrade-Lopes A.L., Godinho R.O. Influence of sex hormones on central and peripheral cholinesterase levels of male and female rats. J. Mol. Neurosci. 2010, 40:246-247.
27. Schmidt E., Schmidt F.W. Sex-differences of plasma cholinesterase in rat. Enzyme 1978, 23:52-55.
28. Weber U., Brank M., Grubic Z. Glucocorticoids differentially control synthesis of acetylcholinesterase and butyrylcholinesterase in rat liver and brain. Chem. Biol. Interact. 1999, 119-120:341-347.
29. Francavilla A., Eagon P.K., Vanthiel D.H., Dileo A., Polimeno L., Starzl T.E. Circadian-rhythms of hepatic estrogen and androgen receptors. Hepatology 1985, 5:1001.
30. Everett J.W. Progesterone and estrogen in the experimental control of ovulation time and other features of the estrous cycle in the rat. Endocrinology 1948, 43:389-405.
31. da Costa V.L., Lapa A.J., Godinho R.O. Short- and long-term influences of calcitonin gene-related peptide on the synthesis of acetylcholinesterase in mammalian myotubes. Br. J. Pharmacol. 2001, 133:229-236.
32. Cardoso C.C., Pereira R.T.S., Koyama C.A., Porto C.S., Abdalla F.M.F. Effects of estrogen on muscarinic acetylcholine receptors in the rat hippocampus. Neuroendocrinology 2004, 80:379-386.
33. Wainman P.H.I.L., Shipounoff G.C. The effects of castration and testosterone propionate on the striated perineal musculature in the rat. Endocrinology 1941, 29:975-978.
34. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
35. Illsley N.P., Lamartiniere C.A. Endocrine regulation of rat serum-cholinesterase activity. Endocrinology 1981, 108:1737-1743.
36. McCutcheon J.E., Marinelli M. Age matters. Eur. J. Neurosci. 2009, 29:997-1014.
37. Lewis E.M., Barnett J.F., Freshwater L., Hoberman A.M., Christian M.S. Sexual maturation data for Crl Sprague-Dawley rats: criteria and confounding factors. Drug Chem. Toxicol. 2002, 25:437-458.
38. Weiser M.J., Handa R.J. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009, 159:883-895.
39. Kitay J.I. Sex differences in adrenal cortical secretion in the rat. Endocrinology 1961, 68:818-824.
40. Critchlow V., Liebelt R.A., Bar-Sela M., Mountcastle W., Lipscomb H.S. Sex difference in resting pituitary-adrenal function in the rat. Am. J. Physiol. 1963, 205:807-815.
41. Seale J.V., Wood S.A., Atkinson H.C., Bate E., Lightman S.L., Ingram C.D., Jessop D.S., Harbuz M.S. Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced hypothalamic-pituitary-adrenal axis activity in male and female rats. J. Neuroendocrinol. 2004, 16:516-524.
42. Seale J.V., Wood S.A., Atkinson H.C., Harbuz M.S., Lightman S.L. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats. J. Neuroendocrinol. 2004, 16:989-998.
43. Garcia-Ayllon M.S., Silveyra M.X., Candela A., Compan A., Claria J., Jover R., Perez-Mateo M., Felipo V., Martinez S., Galceran J., Saez-Valero J. Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligation. Hepatology 2006, 43:444-453.
44. Toutant J.P., Massoulie J., Bon S. Polymorphism of pseudocholinesterase in torpedo-marmorata tissues-comparative-study of the catalytic and molecular-properties of this enzyme with acetylcholinesterase. J. Neurochem. 1985, 44:580-592.
45. Edwards J.A., Brimijoin S. Divergent regulation of acetylcholinesterase and butyrylcholinesterase in tissues of the rat. J. Neurochem. 1982, 38:1393-1403.
46. Xu J.W., Gong J., Chang X.M., Luo J.Y., Dong L., Hao Z.M., Jia A., Xu G.P. Estrogen reduces CCL4-induced liver fibrosis in rats. World J. Gastroenterol. 2002, 8:883-887.
47. Liu Y., Shimizu I., Omoya T., Ito S., Gu X.S., Zuo J. Protective effect of estradiol on hepatocytic oxidative damage. World J. Gastroenterol. 2002, 8:363-366.
48. Bjornstrom L., Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 2005, 19:833-842.
49. O'Lone R., Frith M.C., Karlsson E.K., Hansen U. Genomic targets of nuclear estrogen receptors. Mol. Endocrinol. 2004, 18:1859-1875.
50. Eagon P.K., Seguiti S.M., Willett J.E., Rogerson B.J. Hepatic androgen receptor-effects of hormonal alteration. Hepatology 1985, 5:1046.
51. Francavilla A., Eagon P.K., Dileo A., Vanthiel D.H., Panella C., Polimeno L., Amoruso C., Ingrosso M., Aquilino A.M., Starzl T.E. Circadian-rhythm of hepatic cytosolic and nuclear estrogen and androgen receptors. Gastroenterology 1986, 91:182-188.
52. Karczmar A.G. Cholinesterases (ChEs) and the Cholinergic System in Ontogenesis and Phylogenesis; and Non-Classical Roles of Cholinesterases-A Review. Chem. Biol. Interact. 2010, 10.1016/j.cbi.2010.03.009.
53. Simonneaux V., Ribelayga C. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol. Rev. 2003, 55:325-395.
54. Rogawski M.A., Roth R.H., Aghajanian G.K. Melatonin-deacetylation to 5-methoxytryptamine by liver but not brain aryl acylamidase. J. Neurochem. 1979, 32:1219-1226.
55. Beck O., Jonsson G. In vivo formation of 5-methoxytryptamine from melatonin in rat. J. Neurochem. 1981, 36:2013-2018.
56. Markus R.P., Silva C.L.M., Franco D.G., Barbosa J., Ferreira Z.S. Is modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs?. Pharmacol. Ther. 2010, 10.1016/j.pharmthera.2010.02.009.
57. Wu Y.H., Feenstra M.G.P., Zhou J.N., Liu R.Y., Torano J.S., Van Kan H.J.M., Fischer D.F., Ravid R., Swaab D.F. Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J. Clin. Endocrinol. Metab. 2003, 88:5898-5906.
58. Costagli C., Galli A. Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease. Biochem. Pharmacol. 1998, 55:1733-1737.
59. Pandi-Perumal S.R., Srinivasan V., Maestroni G.J.M., Cardinali D.P., Poeggeler B., Hardeland R. Melatonin-nature's most versatile biological signal?. FEBS J. 2006, 273:2813-2838.
60. Mesulam M.M., Geula C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann. Neurol. 1994, 36:722-727.
61. Duysen E.G., Li B., Lockridge O. The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease, Expert Opin. Drug Metab. Toxicol. 2009, 5:523-528.
62. Lockridge O., Duysen E.G., Voelker T., Thompson C.M., Schopfer L.M. Life without acetylcholinesterase: the implications of cholinesterase inhibitor toxicity in AChE-knockout mice. Environ. Toxicol. Pharm. 2005, 19:463-469.
63. Duysen E.G., Li B., Darvesh S., Lockridge O. Sensitivity of butyrylcholinesterase knockout mice to (-)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Toxicology 2007, 233:60-69.